Improved 6-month survival rate in subjects with prostate stem cell antigen positive tumors in a global, randomized phase 2 trial comparing gemcitabine vs. gemcitabine + AGS-1C4D4 (ASP6182) in metastatic pancreatic cancer Meeting Abstract
| Authors: | Hidalgo, M.; O'Reilly, E. M.; Ko, Y. J.; Blaszkowksy, L. S.; Rarick, M. U.; Lima, Cmsr; Ritch, P. S.; Chan, E.; Spratlin, J. L.; Macarulla, T.; McWhirter, E.; Pezet, D.; Lichinitser, M.; Roman, L. D.; Hartford, A.; Jackson, L.; Vincent, M.; Reyno, L.; Wolpin, B. M. |
| Abstract Title: | Improved 6-month survival rate in subjects with prostate stem cell antigen positive tumors in a global, randomized phase 2 trial comparing gemcitabine vs. gemcitabine + AGS-1C4D4 (ASP6182) in metastatic pancreatic cancer |
| Meeting Title: | ESMO 13th World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 22 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2011 Jun 22-25 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2011-06-01 |
| Start Page: | v12 |
| Language: | English |
| ACCESSION: | WOS:000291260100009 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdr285 |
| Notes: | Meeting Abstract: O-0007 -- "Source: Wos" |
